The purple structure shows a nerve cell that has been stained with the dye “mCherry”. The GIRK channels are visible in green.
Image Credit: © RUB, Petra Wahle
Scientific Frontline: Extended "At a Glance" Summary: Opn4L/GIRK1 Optogenetic Tool
The Core Concept: A novel optogenetic tool that utilizes light to selectively inhibit cellular activity by coupling a light-sensitive receptor (Opn4L) to a modified potassium channel (GIRK1).
Key Distinction/Mechanism: Unlike optogenetic tools that primarily activate cells, this construct, when exposed to blue light, opens the GIRK channel in the cell membrane. This activates a downstream G-protein-coupled signaling pathway, selectively reinforcing inhibitory signals and making the cell less excitable.
Major Frameworks/Components:
- Opn4L: A light-sensitive receptor.
- GIRK1: A modified potassium channel.
- G-protein-coupled Receptors (GPCRs): Crucial signal receptors that mediate cellular responses to various stimuli (including light, medications, and signaling molecules like serotonin and dopamine) by activating specific G-proteins.
Branch of Science: Neurobiology, Cellular Biology, Biophysics.
Future Application: The tool is intended to aid in the precise examination and control of signaling mechanisms in neurons, heart muscle cells, and pacemaker cells. It holds potential for researching and addressing diseases characterized by an imbalance between cellular excitation and inhibition, such as cardiac arrhythmias, depression, schizophrenia, and Parkinson's disease.
Why It Matters: By providing precise control over the balance of stimulating and inhibiting cellular signals, this tool opens entirely new applications within optogenetics, allowing for highly targeted interventions in complex signaling pathways.
Researchers hope the tool will help advance research into heart rhythm disorders and other diseases.
Researchers from Ruhr University Bochum have partnered with colleagues in Göttingen, Berlin, Paris, and Essen to develop new optogenetic tools that can selectively inhibit cellular activity using light. These tools could help investigate diseases in which the balance between excitation and inhibition is disrupted, such as cardiac arrhythmias. The team, working alongside Dr. Brix Mücher, Dr. Ida Siveke, and Professor Stefan Herlitze from the Department of General Zoology and Neurobiology at Ruhr University Bochum in Germany, reported its findings in the journal Science Signaling, published online on October 20, 2026.
Optogenetic tools can activate and deactivate nerve cells via light. In the current study, researchers coupled a light-sensitive receptor named Opn4L to a modified potassium channel named GIRK1, which activates a G-protein-coupled signaling pathway.
G-protein-coupled receptors are among the most important signal receptors in animal cells. They respond to various stimuli, including signaling molecules, medications, and light. In addition, they can activate different G-proteins depending on the cell and receptor type, thereby triggering various responses. Serotonin and dopamine receptors are typical examples. Disruptions to these signaling pathways play a key role in depression, schizophrenia, and Parkinson’s disease.
Tests with Neurons and Muscle Cells
In cell culture experiments, the researchers introduced the newly developed optogenetic tool, based on Opn4L/GIRK1, into cerebellar neurons and heart muscle cells. The experiments with cerebellar cells demonstrated that when blue light shines onto the Opn4L receptor, the coupled GIRK channel in the cell membrane opens, activating a downstream G-protein-coupled signaling pathway. This makes the cell less excitable; therefore, the activity of the neurons is inhibited by the activation of the optogenetic tool.
This optical switch also functioned in human heart muscle cells. When researchers exposed the Opn4L/GIRK1 construct to blue light, the spontaneous beating rate of the cultured cells decreased.
“We have developed an optogenetic tool that not only activates a receptor but also selectively reinforces its downstream signaling pathway,” explains Ida Siveke from Ruhr University Bochum. “This allows us to very precisely influence the balance between stimulating and inhibiting signals in individual cells.”
“As a result, the new optogenetic constructs could help us more accurately examine and control the underlying signaling mechanisms in heart muscle cells, pacemaker cells, and neurons in the future,” says optogenetics pioneer Professor Stefan Herlitze. “This opens up entirely new areas of application for optogenetics.”
Published in journal: Science Signaling
Authors: Brix Mücher, Aida Garrido-Charles, Jonas Wietek, Ina Köhler, Michelle Grömmke, Timo Frischmuth, Lukas Cyganek, Benjamin R. Rost, Tobias Bruegmann, Dietmar Schmitz, Deniz Dalkara, Petra Wahle, Ida Siveke, and Stefan Herlitze
Source/Credit: Ruhr-Universität Bochum | Julia Weiler
Edited by: Scientific Frontline
Reference Number: nbio102126_01